Mouse tumour models with a common PIK3CA mutation (H1047R) showed reduced infiltrate of CD8+ T cells and resistance to immunotherapy (anti PD-1) that could be reversed with PI3K inhibition [61]. This evidence concerns the gene CD8A and neoplasm.